Your browser doesn't support javascript.
loading
Removal of endothelial surface-associated von villebrand factor suppresses accelerate datherosclerosis after myocardial infarction.
Ozawa, Koya; Packwood, William; Muller, Matthew A; Qi, Yue; Xie, Aris; Varlamov, Oleg; McCarty, Owen J; Chung, Dominic; López, José A; Lindner, Jonathan R.
Afiliação
  • Ozawa K; Sydney Medical School Nepean, Faculty of Medicine and Health, Department of Cardiology, The University of Sydney, Nepean Hospital, Sydney, NSW, Australia.
  • Packwood W; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, USA.
  • Muller MA; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, USA.
  • Qi Y; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, USA.
  • Xie A; Cardiovascular Division and Robert M. Berne Cardiovascular Research Center, University of Virginia, Box 801394, 415 Lane Rd, Charlottesville, VA, 22908, USA.
  • Varlamov O; Oregon National Primate Research Center, Portland, OR, USA.
  • McCarty OJ; Department of Biomedical Engineering, Oregon Health & Science University, Portland, USA.
  • Chung D; BloodWorks Research Institute, University of Washington, Seattle, WA, USA.
  • López JA; BloodWorks Research Institute, University of Washington, Seattle, WA, USA.
  • Lindner JR; Cardiovascular Division and Robert M. Berne Cardiovascular Research Center, University of Virginia, Box 801394, 415 Lane Rd, Charlottesville, VA, 22908, USA. jlindner@virginia.edu.
J Transl Med ; 22(1): 412, 2024 May 01.
Article em En | MEDLINE | ID: mdl-38693516
ABSTRACT

BACKGROUND:

Thromboinflammation involving platelet adhesion to endothelial surface-associated von Willebrand factor (VWF) has been implicated in the accelerated progression of non-culprit plaques after MI. The aim of this study was to use arterial endothelial molecular imaging to mechanistically evaluate endothelial-associated VWF as a therapeutic target for reducing remote plaque activation after myocardial infarction (MI).

METHODS:

Hyperlipidemic mice deficient for the low-density lipoprotein receptor and Apobec-1 underwent closed-chest MI and were treated chronically with either (i) recombinant ADAMTS13 which is responsible for proteolytic removal of VWF from the endothelial surface, (ii) N-acetylcysteine (NAC) which removes VWF by disulfide bond reduction, (iii) function-blocking anti-factor XI (FXI) antibody, or (iv) no therapy. Non-ischemic controls were also studied. At day 3 and 21, ultrasound molecular imaging was performed with probes targeted to endothelial-associated VWF A1-domain, platelet GPIbα, P-selectin and vascular cell adhesion molecule-1 (VCAM-1) at lesion-prone sites of the aorta. Histology was performed at day 21.

RESULTS:

Aortic signal for P-selectin, VCAM-1, VWF, and platelet-GPIbα were all increased several-fold (p < 0.01) in post-MI mice versus sham-treated animals at day 3 and 21. Treatment with NAC and ADAMTS13 significantly attenuated the post-MI increase for all four molecular targets by > 50% (p < 0.05 vs. non-treated at day 3 and 21). On aortic root histology, mice undergoing MI versus controls had 2-4 fold greater plaque size and macrophage content (p < 0.05), approximately 20-fold greater platelet adhesion (p < 0.05), and increased staining for markers of platelet transforming growth factor-ß1 signaling. Accelerated plaque growth and inflammatory activation was almost entirely prevented by ADAMTS13 and NAC. Inhibition of FXI had no significant effect on molecular imaging signal or plaque morphology.

CONCLUSIONS:

Plaque inflammatory activation in remote arteries after MI is strongly influenced by VWF-mediated platelet adhesion to the endothelium. These findings support investigation into new secondary preventive therapies for reducing non-culprit artery events after MI.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de von Willebrand / Proteína ADAMTS13 / Infarto do Miocárdio Limite: Animals Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de von Willebrand / Proteína ADAMTS13 / Infarto do Miocárdio Limite: Animals Idioma: En Ano de publicação: 2024 Tipo de documento: Article